Fundraising Fox
Silver Creek Pharmaceuticals
San Francisco, US · Delaware corporation
Find your way into Silver Creek Pharmaceuticals
Sign up to see every warm intro you have to Silver Creek Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Silver Creek Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Silver Creek develops growth factor-based therapeutics to promote cell survival and growth in response to injury. The company focuses on rescuing damaged cells through targeted biologic interventions.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$12.6M disclosed across 2 rounds · 2016–2022
▶$9.2MraisedFeb 2022 · 22 investors · PharmaceuticalsRule 506(b)
- Lakhmir ChawlaExecutive Officer
- James D. MarksDirector
- Mark AgneDirector
- Kris KuchenbeckerExecutive Officer
- Nick TaylorDirector
- Timothy ThrosbyExecutive Officer, Director
- Thomas J. MurtaghDirector
- Offering amount
- $25M
- Amount sold
- $9.2M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedDec 2016 · 13 investors · PharmaceuticalsRule 506(b)
- James MarksDirector
- Ross BreckenridgeExecutive Officer, Director
- Michael FairbanksDirector
- Ulrik NielsenDirector
- Tom MurtaghDirector
- Birgit SchoeberlExecutive Officer, Director
- Offering amount
- $19.8M
- Amount sold
- $3.4M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Silver Creek Pharmaceuticals went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Silver Creek Pharmaceuticals.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $221.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Silver Creek Pharmaceuticals do?
- Silver Creek develops growth factor-based therapeutics to promote cell survival and growth in response to injury. The company focuses on rescuing damaged cells through targeted biologic interventions.
- How much funding has Silver Creek Pharmaceuticals raised?
- Silver Creek Pharmaceuticals has disclosed $12.6M raised across 2 rounds.
- Where is Silver Creek Pharmaceuticals headquartered?
- Silver Creek Pharmaceuticals is headquartered in San Francisco, US.